German industrial giant Siemens has acquired the particle therapy division of Danfysik A/S for an undisclosed sum, reports Erhvervsbladet. Danfysik manufactures the particle accelerators that form key elements of Siemens Particle Therapy solution, an advanced technology used in cancer treatment.
The deal, which is subject to approval by anti-trust authorities and is expected to closed by late October, will see the business and its 107 employees become part of Siemens A/S Denmark.
Siemens and Danfysik have collaborated for four years on the development and use of particle accelerators that bring protons or heavier ions up to 70% of the speed of light. These particles have a high degree of accuracy when applied to tumour cells and are able to destroy the targeted cells while minimizing damage to surrounding tissue.
Jukka Pertola, CEO of Siemens, says in a press release: “This acquisition enables us to take a leading market position in Denmark in the development of particle therapy and we will be able to obtain the next level of clinical integration in cancer treatment to the benefit of our customers and – even more important – the patients. We are very pleased to welcome our new colleagues from Danfysik.”
Søren Rathmann, Chairman of Danfysik, commented that it was natural for Siemens to take over the particle therapy division. "We are very proud and excited that these activities can continue in a global company like Siemens with strong ambitions in particle therapy," he said.